R.H.O. (ASBL)

Active

VAT

BE 0452.611.502

Full name

Groupement Radiothérapie Hématologie Oncologie

Address

Boulevard du Jardin Botanique 32

1000 Bruxelles

Established

17-03-1994

Principal activity

Activities of general hospitals, except geriatric and specialised hospitals

Try for free

Crisis resilience of R.H.O.

Which companies are best armed against current economic trends and the energy crisis?

2023		2022		2021		2020
Profit/Loss	-€229,251	-146%	-€93,163	-467%	€25,413	208%	-€23,573
Equity	€1,632,388	-12%	€1,861,640	-5%	€1,954,802	1%	€1,929,389
Gross margin	-€218,285	-141%	-€90,709	-416%	€28,661	236%	-€21,111

Publications in the Belgian Official Journal for R.H.O.

Type	Date	Pdf	Subject
	26-02-2024		Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
	10-07-2019		Resignations, Appointments (FR)
	27-07-2018		Resignations, Appointments (FR)
	23-07-2012		Resignations, Appointments (FR)
	28-06-2011		Resignations, Appointments (FR)

Sources

Frequently asked questions

What is the VAT number of Groupement Radiothérapie Hématologie Oncologie?

The VAT number of Groupement Radiothérapie Hématologie Oncologie is BE0452611502.

When was Groupement Radiothérapie Hématologie Oncologie founded?

Groupement Radiothérapie Hématologie Oncologie was founded on 17-03-1994.

What is the address of Groupement Radiothérapie Hématologie Oncologie?

The current registered office of Groupement Radiothérapie Hématologie Oncologie is located at Boulevard du Jardin Botanique 32, 1000 Bruxelles.

When was the last time Groupement Radiothérapie Hématologie Oncologie filed their annual financial statements?

The most recent financial statements of Groupement Radiothérapie Hématologie Oncologie were filed on 09-07-2024. You can view them here.

How many employees does Groupement Radiothérapie Hématologie Oncologie have?

There are currently no employees working at Groupement Radiothérapie Hématologie Oncologie or no workforce information is available.

What is the annual turnover of Groupement Radiothérapie Hématologie Oncologie?

At the time of its most recent financial statements, Groupement Radiothérapie Hématologie Oncologie did not publish any turnover figures. Groupement Radiothérapie Hématologie Oncologie reported a gross margin of -€218,285.41.